Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-096763
Filing Date
2024-11-12
Accepted
2024-11-12 16:00:24
Documents
43
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0219288-10q_pluri.htm   iXBRL 10-Q 480603
2 CERTIFICATION ea021928801ex31-1_pluri.htm EX-31.1 9583
3 CERTIFICATION ea021928801ex31-2_pluri.htm EX-31.2 9834
4 CERTIFICATION ea021928801ex32-1_pluri.htm EX-32.1 3442
5 CERTIFICATION ea021928801ex32-2_pluri.htm EX-32.2 3565
  Complete submission text file 0001213900-24-096763.txt   2957022

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE plur-20240930.xsd EX-101.SCH 24182
7 XBRL CALCULATION FILE plur-20240930_cal.xml EX-101.CAL 31339
8 XBRL DEFINITION FILE plur-20240930_def.xml EX-101.DEF 134542
9 XBRL LABEL FILE plur-20240930_lab.xml EX-101.LAB 297743
10 XBRL PRESENTATION FILE plur-20240930_pre.xml EX-101.PRE 156411
46 EXTRACTED XBRL INSTANCE DOCUMENT ea0219288-10q_pluri_htm.xml XML 248953
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 241447706
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)